News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Belsky Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2023 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 195,000 options to buy
@ $6.84, valued at
$1.3M
|
|
| 01/07/2022 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 140,000 options to buy
@ $14.55, valued at
$2M
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 15,384 shares
@ $2.6, valued at
$40k
|
|
| 01/13/2020 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 90,000 options to buy
@ $3.29, valued at
$296.1k
|
|
| 11/13/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 800 shares
@ $2.7588, valued at
$2.2k
|
|
| 09/10/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 60,000 options to buy
@ $3.38, valued at
$202.8k
|
|
| 08/21/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 200 shares
@ $4.42, valued at
$884 |
|
| 08/12/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 500 shares
@ $4.82, valued at
$2.4k
|
|
| 07/26/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Bought 444 shares
@ $5.654, valued at
$2.5k
Bought 56 shares
@ $5.8, valued at
$324.8 |
|
| 01/08/2019 |
4
| Belsky Marc (CFO) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Granted 60,000 options to buy
@ $22.85, valued at
$1.4M
|
|
| 02/28/2018 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 3,000 shares
@ $0
Granted 18,000 options to buy
@ $18.69, valued at
$336.4k
|
|
| 02/07/2018 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 1,048 shares
@ $18.42, valued at
$19.3k
|
|
| 09/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/09/2017 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 08/29/2016 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 04/26/2016 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 04/08/2016 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 03/31/2016 |
4
| Belsky Marc (Senior Vice President and CFO) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC |
| 10/15/2009 |
4
| Belsky Marc (VP Finance & CAO) has filed a Form 4 on CELL GENESYS INC|
Txns:
| Disposed/sold 6,456
@ $0
Disposed/sold 55,000
@ $1.84, valued at
$101.2k
Disposed/sold 50,000
@ $3.8, valued at
$190k
|
|
| 08/01/2008 |
4
| Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC|
Txns:
| Paid exercise price by delivering 3,664
@ $3.105, valued at
$11.4k
|
|
| 02/08/2008 |
4
| Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC|
Txns:
| Granted 55,000
@ $1.84, valued at
$101.2k
|
|
| 08/01/2007 |
4
| Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC|
Txns:
| Granted 10,120
@ $0 |
|
| 12/05/2006 |
4
| Belsky Marc (VP Finance and CAO) has filed a Form 4 on CELL GENESYS INC|
Txns:
| Granted 50,000
@ $3.8, valued at
$190k
|
|
|
|